AMGEN, INC. for AMGEN INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BEIER | N/A |
| CHAKA BURGESS | N/A |
| L NICOLE CURRIE | N/A |
| RODGER CURRIE | N/A |
| ANDREW FOX | N/A |
| KIMBERLY GRECO | N/A |
| MARA GUARDUCCI | N/A |
| JESSE KERNS | N/A |
| KIMBERLY LINTHICUM | — |
| CHRISTOPHER MANCILL | N/A |
| REBECCA MANDELL | N/A |
| HOWARD MOON | N/A |
| THOMAS MOORE | N/A |
| WILLIAM O'BRIEN | N/A |
| SCOTT OLSEN | N/A |
| GREGORY PORTNER | N/A |
| HELEN RHEE | N/A |
| ANDREW SWIRE | N/A |
Taxation/Internal Revenue Code TAX
Corporate Tax Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BEIER | N/A |
| CHAKA BURGESS | N/A |
| L NICOLE CURRIE | N/A |
| RODGER CURRIE | N/A |
| ANDREW FOX | N/A |
| KIMBERLY GRECO | N/A |
| MARA GUARDUCCI | N/A |
| JESSE KERNS | N/A |
| KIMBERLY LINTHICUM | — |
| CHRISTOPHER MANCILL | N/A |
| REBECCA MANDELL | N/A |
| HOWARD MOON | N/A |
| THOMAS MOORE | N/A |
| WILLIAM O'BRIEN | N/A |
| SCOTT OLSEN | N/A |
| GREGORY PORTNER | N/A |
| HELEN RHEE | N/A |
| ANDREW SWIRE | N/A |
Copyright/Patent/Trademark CPT
Intellectual property and process patent issues S. 1145 and S. 1908 – Patent Reform Act of 2007
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BEIER | N/A |
| CHAKA BURGESS | N/A |
| L NICOLE CURRIE | N/A |
| RODGER CURRIE | N/A |
| ANDREW FOX | N/A |
| KIMBERLY GRECO | N/A |
| MARA GUARDUCCI | N/A |
| JESSE KERNS | N/A |
| KIMBERLY LINTHICUM | — |
| CHRISTOPHER MANCILL | N/A |
| REBECCA MANDELL | N/A |
| HOWARD MOON | N/A |
| THOMAS MOORE | N/A |
| WILLIAM O'BRIEN | N/A |
| SCOTT OLSEN | N/A |
| GREGORY PORTNER | N/A |
| HELEN RHEE | N/A |
| ANDREW SWIRE | N/A |
Health Issues HCR
Follow-On-Biologics S. 623 and H.R. 1038 – Access to Life-Saving Medicines Act H.R. 1956 – Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1695 - Biologics Price Competition and Innovation Act of 2007 FDA Drug Safety Oversight S.1082 – Prescription Drug User Fee Amendments of 2007 H.R. 2900 – Food and Drug Administration Amendments Act of 2007
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BEIER | N/A |
| CHAKA BURGESS | N/A |
| L NICOLE CURRIE | N/A |
| RODGER CURRIE | N/A |
| ANDREW FOX | N/A |
| KIMBERLY GRECO | N/A |
| MARA GUARDUCCI | N/A |
| JESSE KERNS | N/A |
| KIMBERLY LINTHICUM | — |
| CHRISTOPHER MANCILL | N/A |
| REBECCA MANDELL | N/A |
| HOWARD MOON | N/A |
| THOMAS MOORE | N/A |
| WILLIAM O'BRIEN | N/A |
| SCOTT OLSEN | N/A |
| GREGORY PORTNER | N/A |
| HELEN RHEE | N/A |
| ANDREW SWIRE | N/A |
Medicare/Medicaid MMM
Implementation of H.R. 1 Medicare Prescription Drug & Modernization Act of 2003 Medicare coverage and reimbursement of Erythropoiesis-Stimulating Agents Implementation of Medicaid Drug Rebate provisions of the Deficit Reduction Act of 2005
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BEIER | N/A |
| CHAKA BURGESS | N/A |
| L NICOLE CURRIE | N/A |
| RODGER CURRIE | N/A |
| ANDREW FOX | N/A |
| KIMBERLY GRECO | N/A |
| MARA GUARDUCCI | N/A |
| JESSE KERNS | N/A |
| KIMBERLY LINTHICUM | — |
| CHRISTOPHER MANCILL | N/A |
| REBECCA MANDELL | N/A |
| HOWARD MOON | N/A |
| THOMAS MOORE | N/A |
| WILLIAM O'BRIEN | N/A |
| SCOTT OLSEN | N/A |
| GREGORY PORTNER | N/A |
| HELEN RHEE | N/A |
| ANDREW SWIRE | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.